In this online exclusive, partners from Hogan Lovells International, Andreas von Falck and Miriam Gundt (Dusseldorf), discuss recent trends in patent protection within the pharmaceutical sector.
Legal
Innovations in the pharma sector are based on patent protection. Originators are amongst the most innovative companies, applying for a large number of patents each year. The development of new pharmaceuticals would not work without fair and effective patent protection, including the right to exclude others from using the new pharmaceutical inventions for a defined period of time.